Clinical Trial Update: A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating a combination of liposomal doxorubicin, docetaxel, trastuzumab, and metformin in operable and locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Trastuzumab (trastuzumab)
• liposomal doxorubicin (doxorubicin liposomal)
• metformin (metformin)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: HER-2 Positive Breast Cancer | Phase 2 | Status: COMPLETED